S2 Peptide-Conjugated SARS-CoV-2 Virus-like Particles Provide Broad Protection against SARS-CoV-2 Variants of Concern
Chang-Kyu Heo(Korea Research Institute of Bioscience and Biotechnology), Eun‐Wie Cho(Korea Research Institute of Bioscience and Biotechnology)
Cited by 2
Related Papers
Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma
|Scientific Reports|2019|30
Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern
|Frontiers in Immunology|2023|9
Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide‑conjugated BSA
|International Journal of Oncology|2022|3